课题基金 / 基金详情

Mechanisms of benign neonatal familial convulsions

Mechanisms of benign neonatal familial convulsions
良性新生儿家族性惊厥的机制
批准号:
7060229
负责人:
EDWARD C COOPER
金额:
$3.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31

项目摘要

项目成果

EDWARD C COOPER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):仔细研究罕见孟德尔形式的人类神经系统疾病的基因是深入了解常见相关疾病的原因、治疗和潜在治愈的有力方法。神经元KCNQ基因是最近发现的,作为寻找导致良性家族性新生儿惊厥的突变基因的结果,良性家族性新生儿惊厥是一种常染色体显性癫痫综合征,与婴儿期和整个生命期的癫痫发作相关。神经元KCNQ基因突变也会导致肌震颤(一种周围神经疾病)和耳聋。KCNQ基因编码电压依赖性钾通道的亚基。所提出的工作的长期目标是了解这些神经元KCNQ通道的体内功能,以便更好地了解基本的脑信号传导机制,并利用这些机制进行神经治疗。KCNQ通道通过其在脑中特定位置的内在电压门控活性以及通过其作为神经递质受体和细胞内信号传导途径的效应器的能力来调节神经元兴奋性。确定KCNQ通道在脑回路中的具体位置,以及受体和通路如何调节其在脑中的活动,将增强我们利用M通道作为治疗靶点的能力,这些靶点涉及过度兴奋或调节性神经传递的改变和失衡,如癫痫,疼痛综合征和阿尔茨海默病。目前的建议集中在隔膜和海马体中的特定脑回路,以及特定的突触前和突触后定位,研究人员和其他人先前的工作表明KCNQ通道发挥重要作用。具体目标是:(1)定位KCNQ亚基在哺乳动物发育和成熟脑中隔海马网络中的定位:(2)确定KCNQ 2亚基在脑、脊髓和周围神经中轴突起始段和Ranvier结的靶向和稳定机制;以及(3)分析KCNQ通道在突变小鼠品系中的定位和功能,所述突变小鼠表现出由于显性-KCNQ 2亚基的负突变体。
英文摘要
DESCRIPTION (provided by applicant): Careful study of genes responsible for rare mendelian forms of human neurological disorders is a powerful approach for gaining insight into the causes, treatment, and potential cure for common, related diseases. The neuronal KCNQ genes were recently discovered as the result of the search for mutant genes causing Benign Familial Neonatal Convulsions, an autosomal dominant epileptic syndrome associated with seizures in infancy and throughout life. Mutations in neuronal KCNQ genes also result in myokymia (a peripheral nerve disorder) and deafness. The KCNQ genes encode subunits of voltage-dependent potassium channels The long term goals of the proposed work is to understand the in vivo functions of these neuronal KCNQ channels, in order to better understand basic brain signaling mechanisms and to exploit these mechanisms for neurological therapeutics. KCNQ channels regulate neuronal excitability through their intrinsic, voltage-gated activity at particular locations in brain, and through their ability to serve as effectors for neurotransmitter receptors and intracellular signaling pathways. Determining specifically where KCNQ channels are localized in brain circuits, and how receptors and pathways modulate their activity in the brain, will enhance our ability to exploit M-channels as therapeutic targets in conditions involving excessive excitability or alterations and imbalances in modulatory neurotransmission, such as epilepsy, pain syndromes, and Alzheimer's disease. The current proposal focuses on particular brain circuits in the septum and hippocampus, and particular presynaptic and post-synaptic localizations, where previous work by the investigator and others indicates KCNQ channels play important roles. The specific aims are to: (1) map the localization of KCNQ subunits in mammalian septohippocampal networks in developing and mature brain; (2) define the mechanisms of targeting and stabilization of KCNQ2 subunits at axon initial segments and nodes of Ranvier in brain, spinal cord, and peripheral nerve; and (3) analyze the localization and function of KCNQ channels in lines of mutant mice that exhibit hyperexcitability and epilepsy due to expression of a dominant-negative mutant of the KCNQ2 subunit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A - Variant prioritization and curation core
Core A - Variant prioritization and curation core
KCNQ2 Epileptic Encephalopathy: Overcoming Hurdles to Effective Disease-Modifying Therapy
  • 批准号:
    9053030
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2015
  • 负责人:
    EDWARD C COOPER
  • 依托单位:
KCNQ2/3 channels in neonatal-onset epilepsy and encephalopathy
  • 批准号:
    8844130
  • 项目类别:
  • 资助金额:
    $2.83万
  • 财政年份:
    2014
  • 负责人:
    EDWARD C COOPER
  • 依托单位:
海外基金